Biophytis announces ordinary and extraordinary shareholder meeting
BPTS•Biophytis will hold a shareholder meeting on November 12, 2026, to consider capital-raising authorizations of up to EUR 38 million each, a reverse split of up to 100-for-1 and other proposals. The agenda also includes 2025 accounts showing a EUR 8.21 million loss and no proposed dividend.
1. Meeting agenda
Biophytis will hold its ordinary and extraordinary shareholders’ meeting on November 12, 2026, at Silver Innov in Ivry-sur-Seine, France. Shareholders will vote on capital-raising authorizations of up to EUR 38 million each, including private placements capped at 30% of capital annually.
2. Other proposals
The proposals include capital reductions that would lower nominal share value to no less than EUR 0.001, a reverse split of up to 100-for-1, and a buyback of up to 10% of capital at a maximum EUR 0.10 per share over 18 months. The agenda includes adopting 2025 accounts showing a EUR 8.21 million loss, with no dividend proposed.
